The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT03313011
Status
Recruiting
Apply to this trial

Conditions

  • Apraxia of Speech
  • Non-fluent Aphasia
  • Primary Progressive Aphasia
  • Primary Progressive Nonfluent Aphasia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Testing protocol for the study — DIAGNOSTIC_TEST
    All patients will see a Neurologist for a neuro exam and consult, see a Speech Pathologist for assessment of speech and language skills, see the Study Coordinator for neuropsych testing (brief tests of thinking, memory, visual spatial skills, etc), undergo an MRI of the brain and a DaTscan of the brain.

Study Details

The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.

Key Dates

Start date
Aug 1, 2017
Status verified
Apr 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
47 participants (estimated)

Arms

  • Arm: Progressive Apraxia of Speech

Primary Outcome Measure

Distinguish types of Progressive Apraxia of Speech [ Time Frame: 1-2 years after baseline imaging ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Sarah M Boland, CCRP
[email protected]
507-284-3863
Keith A Josephs, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies